$Jiutian Chemical (C8R.SG)$ The Board of Directors of Jiutia...
$Jiutian Chemical (C8R.SG)$
The Board of Directors of Jiutian Chemical Group Limited (the “Company”, and together with its subsidiaries, the “Group”) wishes to announce that following a review of the unaudited results for the half year ended 30 June 2021 (“1H2021”), the Group is expected to report a significant increase in consolidated net profit, compared to the respective corresponding prior year period.
The Board of Directors of Jiutian Chemical Group Limited (the “Company”, and together with its subsidiaries, the “Group”) wishes to announce that following a review of the unaudited results for the half year ended 30 June 2021 (“1H2021”), the Group is expected to report a significant increase in consolidated net profit, compared to the respective corresponding prior year period.
The expected profit growth is mainly due to increase in both average selling price and sales volume of our main products, Dimethylformamide (“DMF”) and methylamine. As China’s post Covid-19 economic recovery gathered momentum, we continued to experience strong demand for our main products from the start of 2021.
The Company is in the process of finalising its unaudited condensed interim financial statement for the six months ended 30 June 2021 will be released before 14 August 2021. Further details on the Company’s financial performance and operations will be made available in the aforementioned announcement.
https://links.sgx.com/FileOpen/Profit%20Guidance%201H2021.ashx?App=Announcement&FileID=677733
https://links.sgx.com/FileOpen/Profit%20Guidance%201H2021.ashx?App=Announcement&FileID=677733
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
